Navigation Links
Mach One Corporation Announces Hand Carried Product as a Potential Solution to Swine Flu (H1N1) Virus
Date:5/11/2009

Product Will Create A Barrier To Block The Attachment Of The Virus To The Nasal Membranes

BELGIUM, Wis., May 11 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces the development of a immunoglobulins based product that can be hand carried and used as needed to form a mechanical barrier to block the attachment of the virus to the nasal membranes.

Peter Nash, Ph.D. and Chief Science Officer of Mach One Corporation said, "Having worked with the influenza virus group since 1974, the current strain of influenza Swine Flu (H1N1) appears to be similar to the swine influenza A (H1N1) triple reassortant virus, A/Wisconsin/87/2005 H1N1. This strain of virus is in the influenza virus group that is one of the most frequently occurring human illnesses and is responsible for substantial morbidity and economic loss. Viral inhibitors in the form of active immunoglobulins are effective anti-viral agents in vitro and in vivo. The primary site of attachment for these viruses appears to be in the nasal membrane. They spread from the nasal region into the pharyngeal region and can lead to lower respiratory infection leading to pneumonia and possible death. The proposed new product line could be engineered to be carried in one's pocket. As needed, this type of product would allow for delivery to the direct area of the nasal membrane and block initial attachment in the nasal membrane. This gives a mechanical barrier to protect the person until their own immune system can build-up protection. This should slow the frequency of the virus in the environment."

Dr. Nash continued, "When blockage of the attachment of the virus is the objective, the immunoglobulin package is supplied to humans prior to exposure or immediately after an outbreak. The substantial prevention of viruses in the nasal pharyngeal region tract of humans will ultimately permit substantial reduction or elimination of the virus. This repression or blocking of virus will permit a significant decrease in shedding and passage of the virus from host to host. In addition, the resulting decrease in shedding should further enhance the prevention of epidemic and pandemics."

About Mach One Corporation:

Mach One Corporation (www.machonecorp.com) is a global wellness company that provides biotechnology based solutions to help address one of the world's most pressing and costly needs -- positive, long-term health and longevity benefits for humans and disease-threatened animals of commercial operations. While animal wellness, organic and sustainable products are our initial primary focus, we intend in the near future to add Nutraceuticals to our growing list of operating groups. As an ongoing objective we intend to be agile and swift in spotting business opportunities and respective businesses to expand our vision for positive contribution to global wellness.

Cautionary Statement: This news release may include certain "Forward-looking statements" within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release.


'/>"/>
SOURCE Mach One Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 2017 , ... Forty-five percent of American respondents feel that ... or friends have also commented about their poor hearing. However, only 13 percent ... reason, suggested by 89 percent of American respondents, is that they don’t want ...
(Date:2/22/2017)... ... , ... Social media marketing is transitioning from a singular person activity to ... delves into this insight and more in its latest episode of its Brains Over ... up with social media strategist and partner of the digital firm Med|Ed Digital Jessica ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a recent ... the patient context (age, illness and life choices) should be dissociated from medical ... In addition, all too often, studies regarding health system performance in ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has a passion for using ... family to know all about it for optimal health. Wanting to share her knowledge ... Detox, Digestive and Wellness Solutions ” (published by Balboa Press AU). , This ...
(Date:2/21/2017)... , ... February 21, 2017 , ... Doctors on Liens ... directed by Dr. Kendell Mendonca , to its growing network of doctors in ... including injuries stemming from car accidents such as whiplash, back pain, neck pain, hip ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company ... field of urology, today announced the expansion of its ... from 35 currently, a 20% increase in the company,s ... is being driven by the increasing growth of Natesto, ... acceptance of Natesto,s unique product profile and clinical benefits. ...
(Date:2/22/2017)... -- CVS Pharmacy is the first national retail pharmacy chain ... the primary source of artificial trans fats in processed ... The retailer now offers over 600 exclusive snack and ... comes a year and a half ahead of the ... processed foods to be reformulated without artificial trans fats, ...
(Date:2/22/2017)... Feb 22, 2017 Nordic Nanovector ASA (OSE: ... novel targeted therapeutics for haematological cancers, will announce its fourth quarter ... ... Nordic Nanovector,s senior management team will take place at 8:30 am ... Oslo Meeting Room: NYLAND The presentation will be recorded ...
Breaking Medicine Technology: